On August 16, 2022, Co-Diagnostics, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased the Company’s publicly traded securities between May 12, 2022 and August 11, 2022.
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.